Background: Atrial fibrillation increases the risk of stroke and death. Anticoagulation therapy
is an effective treatment for stroke prevention, but remains underused in the community. We …

Background While atrial fibrillation is a recognized risk factor for stroke, contemporary data
on trends in stroke incidence after the diagnosis of atrial fibrillation are scarce. Methods and …

Background and Purpose—Prevalence of atrial fibrillation (AF) is increasing, but the impact
on overall burden of stroke is uncertain, as is the proportion that could be attributed to under …

Background and Purpose—Ischemic stroke associated with nonvalvular atrial fibrillation
(NVAF) despite prior anticoagulation may indicate underlying problems that nullify the stroke …

Background Atrial fibrillation (AF) is associated with a 5‐fold increased stroke risk. While
most patients with AF warrant anticoagulation, optimal treatment remains uncertain for …

Background Guidelines for anticoagulation in atrial fibrillation (AF) assume that stroke risk
scheme point scores correspond to fixed stroke rates. However, reported stroke rates vary …

Aims To determine whether changing patterns of anticoagulant use in atrial fibrillation (AF)
have impacted on stroke rates in England. Methods and results English national databases …

Atrial fibrillation (AF) is a major risk factor for ischemic stroke and associated with a 5-fold
higher risk of stroke. In this retrospective cohort study, the incidence of and risk factors for …

Background and Purpose—Prescribing warfarin for atrial fibrillation depends in large part on
the expected reduction in ischemic stroke risk versus the expected increased risk of …

Background and Purpose—Warfarin is the most effective stroke prevention medication for
high-risk individuals with atrial fibrillation, yet it is often underused. This study examined the …